Do Ketamine Lozenges Work for Pain?

If you're living with chronic pain that hasn't responded to opioids, gabapentinoids, or the long list of medications your doctors have cycled through, you've probably started looking beyond the standard playbook. Ketamine lozenges keep coming up in those searches, and it's hard to know what to make of them. You're not alone in wondering.

About 60 million Americans live with chronic pain, and nearly 4 in 10 also live with depression. When opioids lose their effect and side effects pile up, a treatment that works through an entirely different mechanism starts to look worth understanding.

The bottom line: Ketamine lozenges can reduce chronic pain, especially neuropathic pain. But the evidence specific to lozenges is thin. Most research uses intravenous (IV) infusions, results tend to be short-term, and lozenges aren't FDA-approved for pain. They work best as one part of clinician-managed care, not a standalone fix.

What does the Research Show About Ketamine Lozenges for Pain?

The research on ketamine for pain is fairly encouraging, but most of it studies IV infusions rather than lozenges. That distinction matters for how much the findings tell us about lozenges specifically.

A systematic review in the Journal of Pharmacy Practice and Research included 21 randomized controlled trials (RCTs) of oral and sublingual ketamine for pain, but only one study compared sublingual to oral delivery, and it studied acute rather than chronic pain. The authors called for more high-quality primary research before sublingual ketamine enters routine clinical practice.

The most relevant lozenge study is a retrospective case series that followed 29 patients on ketamine lozenges for 2 to 89 months. In that group, mean pain scores dropped from 8.71 to 2.89, and 59% of patients reduced their opioids, gabapentinoids, or benzodiazepines. Dosages ranged from 25 to 600 mg in divided doses.

Most people began at 25 mg three times daily, then increased the dose based on pain and tolerability. But every one of these patients had already responded to inpatient subcutaneous ketamine infusions before starting lozenges, so these were people ketamine already worked for.

The broader ketamine evidence, mostly from IV studies, is clearer but still cautious. A 2023 review from Canada's drug agency (CADTH) found ketamine associated with short-term pain reduction in chronic non-cancer pain, with neuropathic pain showing the strongest support and fibromyalgia the weakest.

A 2025 Cochrane review was more cautious, finding no clear evidence that ketamine reduces chronic pain and rating the data low to very low certainty. That uncertainty spans delivery methods, IV infusions included, and reflects small, short trials rather than proof the drug doesn't work. The reviewers called for larger, high-quality studies.

How Lozenges Compare to IV Infusions

The two forms differ in how they're taken, how much drug reaches your bloodstream, and how well each is studied for pain:

Clinicians adjust lozenge doses upward to make up for the lower bioavailability. The lozenge dissolves partly through the tissue under your tongue, which lets it bypass some of the liver metabolism that swallowed ketamine goes through. Because the dissociative effects tend to be milder, some people tolerate lozenges more easily for ongoing use.

For now, lozenges look like a practical maintenance option, and infusions have more study behind them as a starting point, though high-quality evidence for chronic pain is still thin for both. Whether lozenges help someone who has never tried ketamine hasn't been directly tested, which is part of why this treatment stays clinician-guided and closely monitored.

How Ketamine Lozenges Reduce Pain

Ketamine works differently from opioids and most pain medications. Once you understand how ketamine works, it's clear why it can help when they don't.

In chronic pain, ongoing nerve signals can make N-methyl-D-aspartate (NMDA) receptors in your spinal cord hyperactive, a process called central sensitization. Your nervous system turns up the volume on pain and keeps it there. This shows up as allodynia, where normally painless things start to hurt. It can also bring hyperalgesia, where genuinely painful things hurt far more than they should.

Opioids blunt the initial pain signal, but they do little to turn that volume back down. Ketamine works on the amplification itself by blocking those NMDA receptors.

Ketamine also strengthens your body's own pain-dampening pathways and has anti-inflammatory effects in the spinal cord. Most of these effects happen at low doses well below what causes full dissociation. With lozenges, the lower bioavailability means a gentler experience that can be more practical for repeated use over weeks or months.

What Are the Risks of Ketamine Lozenges?

Most side effects are short-lived. In the oral ketamine data, drowsiness, nausea, dizziness, and mild memory effects were the most common, and about 30% of patients reported no side effects at all. In the lozenge case series, 24% had side effects and only 7% stopped treatment because of them.

Longer-Term Risks

Chronic high-dose ketamine, mostly from recreational use, can cause bladder damage that is irreversible in some cases. Therapeutic doses are much lower, and the lozenge case series reported no bladder problems over years of use, but your clinician should track urinary symptoms throughout treatment.

Ketamine is also a Schedule III controlled substance with real potential for dependence, and long-term data in people using it for pain is limited. That's part of why ongoing safety monitoring matters.

Who Shouldn't Use Ketamine

Ketamine isn't the right choice for everyone. It can be unsafe with certain health conditions, including uncontrolled hypertension or unstable heart disease, a history of psychosis or schizophrenia, severe liver disease, and active substance use disorder. It's also not recommended during pregnancy or breastfeeding.

You can review the full list in the eligibility guide.

Off-Label Status and Compounded Lozenges

Ketamine use for chronic pain is off-label. The FDA approval covers ketamine as an anesthetic only, and ketamine lozenges are compounded products that the FDA doesn't verify for safety or effectiveness.

How Innerwell's At-Home Ketamine Program Works for Pain

Living with pain that won't quit is exhausting, and sorting through treatment options while you're already depleted makes it harder. Innerwell's at-home ketamine therapy program pairs clinical oversight with ongoing support so you're not figuring this out alone.

The process:

1. Clinical evaluation: You start with a virtual assessment where your clinician reviews your pain history, prior treatments, cardiovascular health, medications, and any urinary or psychiatric factors that affect safety. Innerwell screens carefully because ketamine isn't right for everyone.
2. Secure at-home medication delivery: If you're cleared for treatment, you'll receive sublingual ketamine at your door, with adult-signature verification and clear dosing instructions. You also get direct access to your clinician through secure messaging.
3. Guided preparation and integration therapy: Licensed therapists walk you through intention-setting before each session and integration afterward, so you can make sense of what comes up. For chronic pain, that usually means building practical coping strategies alongside the medication and working through the toll that constant pain takes. You can also read the preparation guide.
4. Ongoing monitoring and dosage adjustment: Your clinical team tracks pain scores, blood pressure, and side effects so they can adjust your treatment in real time. Pain dosing tends to run higher and last longer than the doses used for mental health, and that heavier pain dosing is why close monitoring matters.

Pricing and Outcomes

Innerwell's insurance-based pricing starts at $54 per session (Extended plan), with self-pay options from $83 to $125 per session. A one-time medical consult fee applies.

Because chronic pain and mood are so tightly linked, the mood side of treatment matters too. Across Innerwell's members, depression symptoms drop by an average of 69% and anxiety symptoms by 60% over 10 weeks, and 87% notice improvement within the first 4 weeks.

Is Ketamine Therapy for Pain Right for Me?

If you've worked through standard pain treatments without lasting relief, ketamine may be worth exploring, particularly if your pain has a neuropathic component.

You're likely a good fit if you've spent months or years on medications with only partial relief, or if your pain comes alongside depression or anxiety that standard care hasn't touched. Many people with chronic pain find that ketamine's mood effects address more than one problem at once.

Certain medical, psychiatric, substance-use, or pregnancy-related factors can rule out treatment, as outlined above. Honest answers during your evaluation keep you safe and give treatment its best chance of working.

Try Innerwell's Pain Program

When standard pain treatments aren't enough, ketamine works on the central sensitization behind so much chronic pain. Innerwell pairs the medication with licensed clinicians, personalized integration therapy, and real-time monitoring so you have support at every step.

Take our free assessment to see if ketamine therapy might help.

Frequently Asked Questions

Is ketamine treatment for chronic pain legal?

Yes. Licensed clinicians can prescribe ketamine off-label for pain, and Innerwell adheres to state and federal telemedicine regulations. Ketamine laws can vary by state.

How well does ketamine work for pain?

It depends on your type of pain. In one meta-analysis of seven trials, 51.3% of people receiving IV ketamine had positive outcomes, versus 19.4% on placebo. Neuropathic pain tends to respond more reliably than conditions like fibromyalgia, where the effects can be brief.

Is treatment covered by insurance?

Because pain use is off-label, coverage varies. Innerwell offers insurance-based pricing in select states, with per-session costs as low as $54, and transparent self-pay options ranging from $83 to $125 per session.